摘要
本文从中药药名的命名应立足于科学性、传承性和服务于临床应用的原则。提出中药多基源品种的药名分列的必备条件是:分列后的各药其性味、归经、功能主治应有区别,否则难以指导和规范临床用药。《中国药典》2010版收载的金银花与山银花两味药的性味、归经、功能主治无区别,笔者认为二者分列的条件尚不成熟,建议合并,药名定为金银花。二者的基源物种全部保留,药材分成金银花与山银花两种。
Name of the Traditional Chinese medicines should following the principle of scientifi city, inheritance and serving clinical service. Therefore, the article puts forward the necessary condition in the respective name of Chinese medicines from different original. The different Chinese medicine should have different characteristic including properties, tastes, channel tropism, function and indication after classifi cation to guide and manage the clinical application. No difference can be found in properties, tastes, channel tropism, function and indication of Lonicerae Japonicae Flos and Lonicern Flos recorded in Pharmacopoeia of the People's Republic of China published in 2010. In the author's opinion, the classifi cation of them isn't necessary now and suggests the combination of the two medicines. The name of the herb is defined as Lonicerae Japonicae Flos, and both of the original species should be retained, and raw medicinal materials divide into Lonicerae Japonicae Flos and Lonicern Flos.
出处
《中药与临床》
2014年第6期1-2,共2页
Pharmacy and Clinics of Chinese Materia Medica
关键词
金银花
山银花
命名
药典
Lonicerae Japonicae Fols
Lonicern Flos
Name
Pharmacopoeia of the People's Republic of China